News-test – Nuclidium

News & Events

News

Oktober 24, 2025

NUCLIDIUM Featured in BioCentury Emerging Company Profile

NUCLIDIUM was featured by BioCentury in an Emerging Company Profile highlighting the company’s unique copper-based approach in targeted radiotheranostic development

Oktober 8, 2025

NUCLIDIUM Presents Positive Phase I/II Results for First Copper-based PET Diagnostic in Neuroendocrine Tumors at EANM Congress 2025

NUCLIDIUM Presents Positive Phase 1 Results of its Novel PET Imaging Agent 61-Cu-NuriPro™ at SNMMI 2025 Annual Meeting

Events

Events

/ März 21, 2023

NUCLIDIUM at BioEquity & Swiss Biotech Days

Our CEO Leila Jaafar will present the company and our unique copper-based approach at the upcoming conferences. Meet us there!

Nuclidium AG

Nuclidium (DE) GmbH

Follow Us

Nuclidium AG

Nuclidium (DE) GmbH

Follow Us

News & Events

News

NUCLIDIUM Featured in BioCentury Emerging Company Profile

NUCLIDIUM Presents Positive Phase I/II Results for First Copper-based PET Diagnostic in Neuroendocrine Tumors at EANM Congress 2025

Events

NUCLIDIUM at BioEquity & Swiss Biotech Days

We are setting a new standard in precision oncology

Nuclidium AG

Nuclidium (DE) GmbH

Contact

Follow Us